Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2025)

Telix Pharmaceuticals has reported Debt Ratio over the past 3 years, most recently at 0.35 for Q4 2025.

  • Quarterly Debt Ratio fell 7.56% to 0.35 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.38 through Dec 2024, up 1565.86% year-over-year, with the annual reading at 0.35 for FY2025, 7.56% down from the prior year.
  • Debt Ratio was 0.35 for Q4 2025 at Telix Pharmaceuticals, down from 0.38 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.38 in Q4 2024 and troughed at 0.02 in Q4 2023.
  • The 3-year median for Debt Ratio is 0.35 (2025), against an average of 0.25.
  • Year-over-year, Debt Ratio skyrocketed 1565.86% in 2024 and then decreased 7.56% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.02 in 2023, then surged by 1565.86% to 0.38 in 2024, then dropped by 7.56% to 0.35 in 2025.
  • Per Business Quant, the three most recent readings for TLX's Debt Ratio are 0.35 (Q4 2025), 0.38 (Q4 2024), and 0.02 (Q4 2023).